Global Contraceptives Market - Global Forecast To 2030

Share

Global Contraceptives Market - Global Forecast To 2030


 Category : Health Care

 Published: Sep-2022
 Author: SPER Analyst


Global Contraceptives Market is projected to be worth USD 20.27 billion by 2030.

The increase in contraception use has improved health-related outcomes, including maternal and newborn mortality, and decreased the risk of sexually transmitted infections. Additionally, an increase in the proportion of gynaecologists choosing these contraceptives for birth control will boost the industry's expansion in the years to come. The market is expanding due to rising usage of safe and effective oral tablets, increased awareness of contemporary contraceptives, and health issues linked to teenage pregnancies. 

Browse report overview on "Global  Contraceptives Market" at: https://www.sperresearch.com/report-store/Contraceptives.aspx

The market for contraceptive drugs will expand at its fastest rate due to contraceptive devices. Over half of the global market for contraceptive drugs is anticipated to be accounted for by contraceptive devices over the forecast period. There is an increase in knowledge about contemporary contraception as a result of this rising risk. Governments all over the world have consistently funded family planning and sex education initiatives to increase public knowledge of the risks of STDs, which has also accelerated the expansion of the contraceptive drugs market.

Global Contraceptives Market study provides market data by the competitive landscape, revenue analysis, market segments and detailed analysis of key market players such as; Agile Therapeutics, Allergan PLC., Bayer AG, GalaxoSmithKline PLC., Johnson & Johnson, Mylan N.V., Mankind Pharma, Novartis AG, Piramal Healthcare, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd. 
                                                                                                                     
SPER Market Research study aims to provide market dynamics, demand and supply with yearly forecast to 2030. This report provides data for growth estimates and forecasts for product type segment – By Age Group (15-24 Years, 25-34 Years, 35-44 Years, 44 Years), By Product (Oral Contraceptive Pills, Intra-Uterine Devices, Contraceptive Sponges, Subdermal Implants, Vaginal Rings, Condoms, Topical Contraceptives, Injectables, Diaphragms), By Distribution (Hospitals Pharmacies, Online Pharmacies, Independent Pharmacies, Clinics, Others).

Request sample pages for Global  Contraceptives Market report and gain crucial industry insights that will help your business grow at: https://www.sperresearch.com/report-store/Contraceptives.aspx?sample=1

This report also provides the data for key regional segments of North America, Asia-Pacific, Europe, South-America and Rest of the World. 

This study also encompasses various drivers and restraining factors of this market for the forecast period. Various growth opportunities are also discussed in the report. 

Join SPER Panel

Our Global Clients

Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
SPER-Astellas Pharma
SPER-Citi Bank
SPER-Microsoft
SPER-EY
SPER-Sanofi
SPER-p&g
SPER-Johnson & Johnson
SPER-SIEMENS
SPER-LOREAL
SPER-Pfizer
SPER-IPSOS
SPER-Heineken
SPER-IQVIA
SPER-Kankar IMRB
SPER-Astellas Pharma
SPER-Citi Bank
SPER-Microsoft
SPER-EY
SPER-Sanofi
SPER-p&g
SPER-Johnson & Johnson
SPER-SIEMENS
SPER-LOREAL
SPER-Pfizer
SPER-IPSOS
SPER-Heineken
SPER-IQVIA
SPER-Kankar IMRB

SPER

Market Research

We are the leading, full-service global market research and consulting company.

Certificates
iso-1 iso-1
Secure Payments
SPER Payment Options
Connect with us